Pemetrexed, Catalog: B1862

IN STOCK!
US$0.00

N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid

PRODUCT SUMMARY

Alternate Names N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid

Appearance White solid

CAS # 137281-23-3

Molecular Formula C₂₀H₂₁N₅O₆

Molecular Weight 427.41

Purity ≥ 98% by HPLC

Solubility DMSO (>40 mg/ml)

SMILES C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O

InChi InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1

InChi Key WBXPDJSOTKVWSJ-ZDUSSCGKSA-N

PubChem CID 446556

MDL Number MFCD19105065

Storage Conditions -20°C

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

Pemetrexed inhibits multiple enzyme targets involved in folate metabolism and pyrimidine and purine synthesis. It is a high affinity dihydrofolate reductase (DHFR) inhibitor (Ki = 7 nM). It also inhibits thymidylate synthase, AICART and glycinamide ribonucleotide formyltransferase (Ki values are 109 nM, and 3.5 μM and 9.3 μM, respectively). Inhibits proliferation of cancer cell lines in vitro.